Antecedent infections in Guillain-Barré syndrome: a single-center, prospective study
- PMID: 31714025
- PMCID: PMC6917331
- DOI: 10.1002/acn3.50946
Antecedent infections in Guillain-Barré syndrome: a single-center, prospective study
Abstract
Objective: To investigate the spectrum of antecedent infections in Chinese patients with Guillain-Barré syndrome (GBS) and analyze the infections-related clinical phenotypes locally.
Methods: A prospective case-control study of 150 patients diagnosed with GBS and age- and sex-matched neurological and healthy controls was performed to investigate recent infections of 14 pathogens serologically and collect the clinical data during a follow-up of 12 months.
Results: In total, 53% of patients with GBS had a positive serology for recent infection, including Campylobacter jejuni (27%), influenza A (17%) and B (16%), hepatitis A virus (5%), dengue virus (3%), cytomegalovirus (3%), Epstein-Barr virus (3%), Mycoplasma pneumoniae (2%), herpes simplex virus (2%), varicella-zoster virus (1%), and rubella virus (1%). Serology for infections of hepatitis E virus, Haemophilus influenzae, and Zika virus was negative. There was a higher frequency of C. jejuni, influenza A, influenza B, and hepatitis A virus infections in GBS patients than both the neurological and healthy controls. C. jejuni infection was more frequent in younger GBS patients and was associated with antibodies against GM1, GalNAc-GD1a, and GM1:galactocerebroside complex. Influenza B infection was associated with a pure motor form of GBS.
Interpretation: C. jejuni, influenza A, influenza B, and hepatitis A virus serve as the most common cause of antecedent infections in GBS locally. Influenza B-related GBS may represent a pure motor phenotype. Differences in the infectious spectrum worldwide may contribute to the geographical clinical heterogeneity of GBS.
© 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.
Conflict of interest statement
The authors report no disclosures relevant to the manuscript.
Figures
References
-
- Willison HJ, Jacobs BC, van Doorn PA. Guillain‐Barré syndrome. Lancet 2016;388:717–727. - PubMed
-
- Doets AY, Verboon C, van den Berg B, et al. Regional variation of Guillain‐Barré syndrome. Brain 2018;141:2866–2877. - PubMed
-
- Jacobs BC, Rothbarth PH, van der Meché FG, et al. The spectrum of antecedent infections in Guillain‐Barré syndrome: a case‐control study. Neurology 1998;51:1110–1115. - PubMed
-
- Meyer Sauteur PM, Huizinga R, Tio‐Gillen AP, et al. Mycoplasma pneumoniae triggering the Guillain‐Barré syndrome: a case‐control study. Ann Neurol 2016;80:566–580. - PubMed
Publication types
MeSH terms
Grants and funding
- 81771298/National Natural Science Foundation of China/International
- 81771360/National Natural Science Foundation of China/International
- 81301072/National Natural Science Foundation of China/International
- 2017SMNS002/Technology boosting new and old kinetic energy conversion projects of Jining City/International
- ZR2017LH034/Shandong Province Natural Science Fund Project/International
LinkOut - more resources
Full Text Sources
Medical
